Exhaled nitric oxide in asthma management
Annals of Allergy, Asthma & Immunology
April 2012 Volume 108, Issue 4, Pages 219-222 MOC/CME Review
Participants will be able to demonstrate increased knowledge of the clinical treatment of allergy/asthma/immunology and how new information can be applied to their own practices
Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Chitra Dinakar, MD (Author)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)
Mitchell H. Grayson, MD (Deputy Editor)
Physicians involved in providing patient care in the field of allergy/asthma/immunology
At the conclusion of this activity, participants should be able to:
● Demonstrate knowledge of the use of exhaled nitric oxide testing in the detection of eosinophilic airway inflammation in asthma
● Demonstrate knowledge of the use of exhaled nitric oxide testing to identify and manage steroid-responsive individuals with asthma
Chitra Dinakar, MD
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance